BCTX logo

BriaCell Therapeutics (BCTX) Current Liabilities

Annual Current Liabilities

$7.46 M
+$5.66 M+314.17%

July 31, 2024

Summary

Performance

1-Year Change

+314.17%

3-Year Change

+1240.01%

5-Year Change

+558.36%

15-Year Change

+742.22%

BCTX Current Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

26.17%
BCTX annual total current liabilities is higher than 26.17% of companies in Healthcare sector

High & Low

All-time High

$7.46 M
BCTX annual total current liabilities is currently at an all-time high

3-Year Low

$556.80 K
BCTX annual total current liabilities is currently +1240.01% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Jul 31, 2024
BCTX previous annual earnings announcement was published on Jul 31, 2024

Next Annual Earnings Report Date

N/A
BCTX next annual earnings announcement has not yet been scheduled

OtherBCTXbalance sheetmetrics:

Annual Total Liabilities

$8.56 M
BCTX annual total liabilities is $8.56 million

Annual Total Long Term Liabilities

$1.10 M
BCTX annual total long term liabilities is $1.10 million

Annual Total Assets

$5.87 M
BCTX annual total assets is $5.87 million

Annual Current Assets

$3.65 M
BCTX annual total current assets is $3.65 million

Quarterly Current Liabilities

$4.99 M
-$2.47 M-33.14%

October 31, 2024

Summary

Performance

3-Month Change

-33.14%

1-Year Change

-26.18%

3-Year Change

+724.43%

5-Year Change

+724.43%

BCTX Quarterly Current Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

18.67%
BCTX quarterly total current liabilities is higher than 18.67% of companies in Healthcare sector

High & Low

All-time High

$7.46 M
BCTX quarterly total current liabilities is currently -33.14% below its historical high of $7.46 million

3-Year Low

$366.30 K
BCTX quarterly total current liabilities is currently +1261.89% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Oct 31, 2024
BCTX previous earnings announcement was published on Oct 31, 2024

Next Quarterly Earnings Report Date

Mar 18, 2025
BCTX next earnings announcement is scheduled for Mar 18, 2025

OtherBCTXbalance sheetmetrics:

Quarterly Total Liabilities

$6.70 M
BCTX quarterly total liabilities is $6.70 million

Quarterly Long Term Liabilities

$1.71 M
BCTX quarterly total long term liabilities is $1.71 million

Quarterly Total Assets

$10.41 M
BCTX quarterly total assets is $10.41 million

Quarterly Current Assets

$8.22 M
BCTX quarterly total current assets is $8.22 million

Current Liabilities Formula

Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities

Annual Current Liabilities

$7.46 M
BCTX annual total current liabilities is $7.46 million

Annual Accounts Payable

$7.17 M
BCTX annual accounts payable is $7.17 million

Annual Short Term Debt

-
BCTX annual short term debt value is unknown

BCTX Current Liabilities Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+314.2%-26.2%
3 y3 years+1240.0%+724.4%
5 y5 years+558.4%+724.4%

BCTX Current Liabilities Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+1240.0%-33.1%+1261.9%
5 y5-yearat high+1240.0%-33.1%+2836.2%
alltimeall timeat high>+9999.0%-33.1%>+9999.0%

BriaCell Therapeutics Current Liabilities History

DateAnnualQuarterly
Oct 2024
-
$4.99 M(-33.1%)
Jul 2024
$7.46 M(+314.2%)
$7.46 M(+10.4%)
Apr 2024
-
$6.76 M(+72.2%)
Jan 2024
-
$3.92 M(+275.0%)
Oct 2023
-
$1.05 M(-41.9%)
Jul 2023
$1.80 M(+91.4%)
$1.80 M(+30.3%)
Apr 2023
-
$1.38 M(+106.3%)
Jan 2023
-
$670.40 K(-31.2%)
Oct 2022
-
$974.00 K(+3.5%)
Jul 2022
$941.10 K(+69.0%)
$941.10 K(+156.9%)
Apr 2022
-
$366.30 K(-39.5%)
Jan 2022
-
$605.10 K(+40.3%)
Oct 2021
-
$431.40 K(-22.5%)
Jul 2021
$556.80 K(-86.0%)
$556.80 K(+227.7%)
Apr 2021
-
$169.90 K(-95.7%)
Jan 2021
-
$3.94 M(+7.1%)
Oct 2020
-
$3.68 M(-7.2%)
Jul 2020
$3.96 M(+249.8%)
$3.96 M(+24.0%)
Apr 2020
-
$3.20 M(+16.6%)
Jan 2020
-
$2.74 M(+112.0%)
Oct 2019
-
$1.29 M(+14.1%)
Jul 2019
$1.13 M(-15.4%)
$1.13 M(+104.1%)
Apr 2019
-
$555.40 K(-64.0%)
Jan 2019
-
$1.54 M(+47.6%)
Oct 2018
-
$1.04 M(-22.0%)
Jul 2018
$1.34 M(+51.2%)
$1.34 M(-1.5%)
Apr 2018
-
$1.36 M(+315.9%)
Jan 2018
-
$327.10 K(-0.7%)
Oct 2017
-
$329.30 K(-62.8%)
Jul 2017
$885.90 K(+1722.8%)
$885.90 K(+6319.6%)
Apr 2017
-
$13.80 K(+84.0%)
Jan 2017
-
$7500.00(-77.2%)
Oct 2016
-
$32.90 K(-32.3%)
Jul 2016
$48.60 K(-58.5%)
$48.60 K(-37.1%)
Apr 2016
-
$77.30 K(-4.3%)
Jan 2016
-
$80.80 K(-23.2%)
Oct 2015
-
$105.20 K(-10.2%)
DateAnnualQuarterly
Jul 2015
$117.20 K(+368.8%)
$117.20 K(-3.6%)
Apr 2015
-
$121.60 K(+2.7%)
Jan 2015
-
$118.40 K(-94.3%)
Oct 2014
-
$2.09 M(+8240.8%)
Jul 2014
$25.00 K(-66.4%)
$25.00 K(-68.5%)
Apr 2014
-
$79.40 K(+0.3%)
Jan 2014
-
$79.20 K(+7.0%)
Oct 2013
-
$74.00 K(-0.7%)
Jul 2013
$74.50 K(-73.8%)
$74.50 K(+106.9%)
Apr 2013
-
$36.00 K(+25.4%)
Jan 2013
-
$28.70 K(-75.3%)
Oct 2012
-
$116.00 K(-59.1%)
Jul 2012
$283.90 K(-60.4%)
$283.90 K(+236.0%)
Apr 2012
-
$84.50 K(+134.1%)
Jan 2012
-
$36.10 K(-89.9%)
Oct 2011
-
$357.20 K(-50.2%)
Jul 2011
$716.70 K(+2354.5%)
$716.70 K(+863.3%)
Apr 2011
-
$74.40 K(-12.9%)
Jan 2011
-
$85.40 K(-6.3%)
Oct 2010
-
$91.10 K(+212.0%)
Jul 2010
$29.20 K(-54.5%)
$29.20 K(-27.7%)
Apr 2010
-
$40.40 K(+329.8%)
Jan 2010
-
$9400.00(-66.8%)
Oct 2009
-
$28.30 K(-55.9%)
Jul 2009
$64.20 K(+311.5%)
$64.20 K(+1046.4%)
Apr 2009
-
$5600.00(-50.9%)
Jan 2009
-
$11.40 K(+293.1%)
Oct 2008
-
$2900.00(-81.4%)
Jul 2008
$15.60 K(+62.5%)
$15.60 K(+437.9%)
Apr 2008
-
$2900.00(-39.6%)
Jan 2008
-
$4800.00(-63.4%)
Oct 2007
-
$13.10 K(+36.5%)
Jul 2007
$9600.00(-41.8%)
$9600.00(+380.0%)
Apr 2007
-
$2000.00(+566.7%)
Jan 2007
-
$300.00(-97.2%)
Oct 2006
-
$10.90 K
Jul 2006
$16.50 K
-

FAQ

  • What is BriaCell Therapeutics annual total current liabilities?
  • What is the all time high annual current liabilities for BriaCell Therapeutics?
  • What is BriaCell Therapeutics annual current liabilities year-on-year change?
  • What is BriaCell Therapeutics quarterly total current liabilities?
  • What is the all time high quarterly current liabilities for BriaCell Therapeutics?
  • What is BriaCell Therapeutics quarterly current liabilities year-on-year change?

What is BriaCell Therapeutics annual total current liabilities?

The current annual current liabilities of BCTX is $7.46 M

What is the all time high annual current liabilities for BriaCell Therapeutics?

BriaCell Therapeutics all-time high annual total current liabilities is $7.46 M

What is BriaCell Therapeutics annual current liabilities year-on-year change?

Over the past year, BCTX annual total current liabilities has changed by +$5.66 M (+314.17%)

What is BriaCell Therapeutics quarterly total current liabilities?

The current quarterly current liabilities of BCTX is $4.99 M

What is the all time high quarterly current liabilities for BriaCell Therapeutics?

BriaCell Therapeutics all-time high quarterly total current liabilities is $7.46 M

What is BriaCell Therapeutics quarterly current liabilities year-on-year change?

Over the past year, BCTX quarterly total current liabilities has changed by -$1.77 M (-26.18%)